PINK1 and parkin complementarily protect dopaminergic neurons in vertebrates

Human Molecular Genetics

Volumn 22, Issue 12, 2013, Pages 2423-2434

  Matsui, Hideaki ^a,c   Gavinio, Roberto ^a,c   Asano, Takeshi ^a   Uemura, Norihito ^a,c   Ito, Hidefumi ^a,d   Taniguchi, Yoshihito ^a,c,e   Kobayashi, Yoshito ^a,c   Maki, Takakuni ^a   Shen, Jie ^b   Takeda, Shunichi ^a,c   Uemura, Kengo ^a,c   Yamakado, Hodaka ^a,c   Takahashi, Ryosuke ^a,c  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE INDUCED KINASE 1; PHOSPHOTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; LOCOMOTION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTOR DYSFUNCTION; ORYZIAS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; DOPAMINE; DROSOPHILA; FISH PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MITOCHONDRIA; NEURONS; ORYZIAS; PARKINSON DISEASE; PHENOTYPE; PROTEIN KINASES; UBIQUITIN-PROTEIN LIGASES; VERTEBRATES;

ANIMALIA; ORYZIAS LATIPES; ORYZIINAE; VERTEBRATA;

EID: 84878472085     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt095     Document Type: Article

References (58)

1. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
2. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
3. Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A. and Guo, M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 441, 1162-1166.
4. Park, J., Lee, S.B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.M. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature, 441, 1157-1161.
5. Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.W., Yang, L., Beal, M.F., Vogel, H. and Lu, B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl Acad. Sci. USA, 103, 10793-10798.
6. Kitada, T., Pisani, A., Porter, D.R., Yamaguchi, H., Tscherter, A., Martella, G., Bonsi, P., Zhang, C., Pothos, E.N. and Shen, J. (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl Acad. Sci. USA, 104, 11441-11446.
7. Gautier, C.A., Kitada, T. and Shen, J. (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc. Natl Acad. Sci. USA, 105, 11364-11369.
8. Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.H., Becker, D., Voos, W., Leuner, K., Muller, W.E., Kudin, A.P. et al. (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PloS One, 4, e5777.
9. Kitada, T., Pisani, A., Karouani, M., Haburcak, M., Martella, G., Tscherter, A., Platania, P., Wu, B., Pothos, E.N. and Shen, J. (2009) Impaired dopamine release and synaptic plasticity in the striatum of parkin2/2 mice. J. Neurochem., 110, 613-621.
10. Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepeda, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J. et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem., 278, 43628-43635.
11. Itier, J.M., Ibanez, P., Mena, M.A., Abbas, N., Cohen-Salmon, C., Bohme, G.A., Laville, M., Pratt, J., Corti, O., Pradier, L. et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum. Mol. Genet., 12, 2277-2291.
12. Von Coelln, R., Thomas, B., Savitt, J.M., Lim, K.L., Sasaki, M., Hess, E.J., Dawson, V.L. and Dawson, T.M. (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc. Natl Acad. Sci. USA, 101, 10744-10749.
13. Kitada, T., Tong, Y., Gautier, C.A. and Shen, J. (2009) Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J. Neurochem., 111, 696-702.
14. Perez, F.A. and Palmiter, R.D. (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl Acad. Sci. USA, 102, 2174-2179.
15. Shin, J.H., Ko, H.S., Kang, H., Lee, Y., Lee, Y.I., Pletinkova, O., Troconso, J.C., Dawson, V.L. and Dawson, T.M. (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell, 144, 689-702.
16. Lin, X., Parisiadou, L., Sgobio, C., Liu, G., Yu, J., Sun, L., Shim, H., Gu, X.L., Luo, J., Long, C.X. et al. (2012) Conditional expression of Parkinson's disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J. Neurosci., 32, 9248-9264.
17. Anichtchik, O., Diekmann, H., Fleming, A., Roach, A., Goldsmith, P. and Rubinsztein, D.C. (2008) Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J. Neurosci., 28, 8199-8207.
18. Flinn, L., Mortiboys, H., Volkmann, K., Koster, R.W., Ingham, P.W. and Bandmann, O. (2009) Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain, 132, 1613-1623.
19. Fett, M.E., Pilsl, A., Paquet, D., van Bebber, F., Haass, C., Tatzelt, J., Schmid, B. and Winklhofer, K.F. (2010) Parkin is protective against proteotoxic stress in a transgenic zebrafish model. PloS one, 5, e11783.
20. Xi, Y., Ryan, J., Noble, S., Yu, M., Yilbas, A.E. and Ekker, M. (2010) Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function. Eur. J. Neurosci., 31, 623-633.
21. Matsui, H., Taniguchi, Y., Inoue, H., Uemura, K., Takeda, S. and Takahashi, R. (2009) A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish. Neurosci. Res., 65, 263-271.
22. Matsui, H., Ito, H., Taniguchi, Y., Inoue, H., Takeda, S. and Takahashi, R. (2010) Proteasome inhibition in medaka brain induces the features of Parkinson's disease. J. Neurochem., 115, 178-187.
23. Matsui, H., Ito, H., Taniguchi, Y., Takeda, S. and Takahashi, R. (2010) Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish. J. Neurochem., 115, 1150-1160.
24. Matsui, H., Taniguchi, Y., Inoue, H., Kobayashi, Y., Sakaki, Y., Toyoda, A., Uemura, K., Kobayashi, D., Takeda, S. and Takahashi, R. (2010) Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement. Neurosci. Res., 66, 151-161.
25. Taniguchi, Y., Takeda, S., Furutani-Seiki, M., Kamei, Y., Todo, T., Sasado, T., Deguchi, T., Kondoh, H., Mudde, J., Yamazoe, M. et al. (2006) Generation of medaka gene knockout models by target-selected mutagenesis. Genome Biol., 7, R116.
26. Narendra, D.P. and Youle, R.J. (2011) Targeting Mitochondrial Dysfunction. Role for PINK1 and Parkin in Mitochondrial Quality Control. Antioxid. Redox Signal., 14, 1929-1938.
27. Berger, A.K., Cortese, G.P., Amodeo, K.D., Weihofen, A., Letai, A. and LaVoie, M.J. (2009) Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum. Mol. Genet., 18, 4317-4328
28. Hao, L.Y., Giasson, B.I. and Bonini, N.M. (2010) DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc. Natl Acad. Sci. USA, 107, 9747-9752.
29. Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., Cookson, M.R. and Youle, R.J. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8, e1000298.
30. Muftuoglu, M., Elibol, B., Dalmizrak, O., Ercan, A., Kulaksiz, G., Ogus, H., Dalkara, T. and Ozer, N. (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord., 19, 544-548.
31. Mortiboys, H., Thomas, K.J., Koopman, W.J., Klaffke, S., Abou-Sleiman, P., Olpin, S., Wood, N.W., Willems, P.H., Smeitink, J.A., Cookson, M.R. et al. (2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann. Neurol., 64, 555-565.
32. Hoepken, H.H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mulsch, A., Nussbaum, R.L., Muller, K., Drose, S., Brandt, U. et al. (2007) Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol. Dis., 25, 401-411.
33. Pridgeon, J.W., Olzmann, J.A., Chin, L.-S. and Li, L. (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol., 5, e172.
34. Wang, H.L., Chou, A.H., Yeh, T.H., Li, A.H., Chen, Y.L., Kuo, Y.L., Tsai, S.R. and Yu, S.T. (2007) PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol. Dis., 28, 216-226.
35. Tatton, N.A. (2000) Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol., 166, 29-43.
36. Hartmann, A., Troadec, J.D., Hunot, S., Kikly, K., Faucheux, B.A., Mouatt-Prigent, A., Ruberg, M., Agid, Y. and Hirsch, E.C. (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci., 21, 2247-2255.
37. Viswanath, V., Wu, Y., Boonplueang, R., Chen, S., Stevenson, F.F., Yantiri, F., Yang, L., Beal, M.F. and Andersen, J.K. (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci., 21, 9519-9528.
38. Morais, V.A., Verstreken, P., Roethig, A., Smet, J., Snellinx, A., Vanbrabant, M., Haddad, D., Frezza, C., Mandemakers, W., Vogt-Weisenhorn, D. et al. (2009) Parkinson's disease mutations in PINK1 result in decreased complex I activity and deficient synaptic function. EMBO Mol. Med., 1, 99-111.
39. Green, D.R., Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.-F., Gautier, C.A., Shen, J., Cookson, M.R. and Youle, R.J. (2010) PINK1 Is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8, e1000298.
40. Exner, N., Treske, B., Paquet, D., Holmstrom, K., Schiesling, C., Gispert,S., Carballo-Carbajal, I., Berg, D., Hoepken, H.H., Gasser, T. et al. (2007) Loss-of-function of human PINK1 results in, mitochondrial pathology and can be rescued by Parkin. J. Neurosci., 27, 12413-12418.
41. Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D.S., Tabrizi, S.J., Wood, N.W. et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell, 33, 627-638.
42. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489.
43. Dawson, T.M., Ko, H.S. and Dawson, V.L. (2010) Genetic animal models of Parkinson's disease. Neuron, 66, 646-661.
44. Bezard, E., Gross, C.E. and Brotchie, J.M. (2003) Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci., 26, 215-221.
45. Palop, J.J., Chin, J. and Mucke, L. (2006) A network dysfunction perspective on neurodegenerative diseases. Nature, 443, 768-773.
46. Exner, N., Lutz, A.K., Haass, C. and Winklhofer, K.F. (2012) Mitochondrial dysfunction in Parkinson's disease. Molecular mechanisms and pathophysiological consequences. EMBO J., 31, 3038-3062.
47. Johnson, B.N., Berger, A.K., Cortese, G.P. and Lavoie, M.J. (2012) The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc. Natl Acad. Sci. USA, 109, 6283-6288.
48. Geisler, S., Holmström, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J. and Springer, W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell. Biol., 12, 119-131.
49. Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R.L.A., Kim, J., May, J., Tocilescu, M.A., Liu, W., Ko, H.S. et al. (2009) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl Acad. Sci. USA, 107, 378-383.
50. Deng, H., Dodson, M.W., Huang, H. and Guo, M. (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl Acad. Sci. USA, 105, 14503-14508.
51. Yang, Y., Ouyang, Y., Yang, L., Beal, M.F., McQuibban, A., Vogel, H. and Lu, B. (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl Acad. Sci. USA,105, 7070-7075.
52. Poole, A.C., Thomas, R.E., Andrews, L.A., McBride, H.M., Whitworth, A.J. and Pallanck, L.J. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl Acad. Sci. USA, 105, 1638-1643.
53. Janssen, A.J.M., Trijbels, F.J.M., Sengers, R.C.A., Smeitink, J.A.M., van den Heuvel, L.P., Wintjes, L.T.M., Stoltenborg-Hogenkamp, B.J.M. and Rodenburg, R.J.T. (2007) Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin. Chem., 53, 729-734.
54. Amo, T., Sato, S., Saiki, S., Wolf, A.M., Toyomizu, M., Gautier, C.A., Shen, J., Ohta, S. and Hattori, N. (2011) Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects. Neurobiol. Dis., 41, 111-118.
55. Kitao, Y., Imai, Y., Ozawa, K., Kataoka, A., Ikeda, T., Soda, M., Nakimawa, K., Kiyama, H., Stern, D.M., Hori, O. et al. (2007) Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum. Mol. Genet., 16, 50-60.
56. Imai, Y. (2000) Parkin suppresses unfolded protein stress-induced cell death through Its E3 ubiquitin-protein ligase Activity. J. Biol. Chem., 275, 35661-35664.
57. Moriwaki, Y., Kim, Y.-J., Ido, Y., Misawa, H., Kawashima, K., Endo, S. and Takahashi, R. (2008) L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner. Neurosci. Res., 61, 43-48.
58. de Wit, L.E.A., Scholte, H.R. and Sluiter, W. (2008) Correct assay of complex I activity in human skin fibroblasts by timely addition of rotenone. Clin. Chem., 54, 1921-1922.